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Abstract
Staphylococcus aureus is a leading cause of bloodstream infections worldwide. In the United States, many of these
infections are caused by a strain known as USA300. Although progress has been made, our understanding of the S. aureus
molecules that promote survival in human blood and ultimately facilitate metastases is incomplete. To that end, we
analyzed the USA300 transcriptome during culture in human blood, human serum, and trypticase soy broth (TSB), a
standard laboratory culture media. Notably, genes encoding several cytolytic toxins were up-regulated in human blood
over time, and hlgA, hlgB, and hlgC (encoding gamma-hemolysin subunits HlgA, HlgB, and HlgC) were among the most
highly up-regulated genes at all time points. Compared to culture supernatants from a wild-type USA300 strain (LAC),
those derived from an isogenic hlgABC-deletion strain (LACDhlgABC) had significantly reduced capacity to form pores in
human neutrophils and ultimately cause neutrophil lysis. Moreover, LACDhlgABC had modestly reduced ability to cause
mortality in a mouse bacteremia model. On the other hand, wild-type and LACDhlgABC strains caused virtually identical
abscesses in a mouse skin infection model, and bacterial survival and neutrophil lysis after phagocytosis in vitro was
similar between these strains. Comparison of the cytolytic capacity of culture supernatants from wild-type and isogenic
deletion strains lacking hlgABC, lukS/F-PV (encoding PVL), and/or lukDE revealed functional redundancy among two-
component leukotoxins in vitro. These findings, along with a requirement of specific growth conditions for leukotoxin
expression, may explain the apparent limited contribution of any single two-component leukotoxin to USA300 immune
evasion and virulence.
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Introduction
Staphylococcus aureus is a leading cause of human bacterial
infections worldwide, many of which are caused by methicillin-
resistant S. aureus (MRSA) (reviewed in refs. [1,2]). Bacteremia is
one of the most abundant syndromes caused by MRSA, especially
in healthcare settings [3]. For example, Klevens et al. reported that
75.2% of all invasive MRSA infections, including those that
originate from community- or healthcare settings, are bacteremias
[3]. A strain known as pulsed-field type USA300 is a leading cause
of community-associated MRSA (CA-MRSA) infections and an
abundant cause of healthcare-associated bloodstream infections in
the United State and Canada [3–7]. The molecules that contribute
to the ability of USA300 (and S. aureus in general) to survive
in human blood and cause significant human disease remain
incompletely defined.
To gain an enhanced understanding of the mechanisms used by
USA300 to survive in blood and cause human disease, we
analyzed the USA300 transcriptome during culture in human
blood and serum in vitro. Although there were a limited number
of genes encoding putative or proven virulence molecules up-
regulated during culture in blood, transcripts encoding gamma-
hemolysin (hlgA, hlgB, and hlgC) were among the most highly
up-regulated USA300 genes over a 2-h culture period in human
blood. Inasmuch as the relative contribution of gamma-hemolysin
to USA300 virulence is not known, we compared the ability
of USA300 wild-type and isogenic hlgABC deletion strains to
circumvent killing by human polymorphonuclear leukocytes and
ultimately cause host cell lysis. In addition, we compared the
ability of these wild-type and mutant strains to cause abscesses and
sepsis in mouse models of infection. Isogenic deletion of genes
encoding multiple USA300 leukotoxins (hlgABC, lukSF-PV, and
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lukDE) singly and in combination indicated functional redundancy
exists among these molecules.
Results
USA300 survival in human blood
As a step toward gaining an enhanced understanding of the
ability of USA300 to cause disseminated disease, we investigated
survival of the pathogen in human blood ex vivo (Fig. 1). Using light
microscopy, we determined that the USA300 strain LAC was
ingested rapidly by phagocytic leukocytes—largely neutrophils—in
human blood (Fig. 1A). At 30 min, some bacteria remained free
and not bound by host phagocytic cells, whereas by 60 min there
were virtually no free bacteria and most neutrophils were loaded
with bacteria (Fig. 1A). Within 90 min, some of the LAC-
containing (or associated) neutrophils had lysed and by 120 min
there were few remaining intact neutrophils (Fig. 1A). These
findings are consistent with the known ability of USA300 to cause
rapid neutrophil lysis after phagocytosis [8,9].
Comparable colony forming units (CFUs) of USA300 were
recovered after 60 min of culture in TSB, serum, and heparinized
human blood (see cultures seeded at 107 CFUs per ml, Fig. 1B).
Although there was a decrease in LAC CFUs by 90 min and
120 min of culture in human blood at the highest inoculum used,
this phenomenon was at least in part attributed to aggregation of
blood cells and bacteria (discussed below). Taken together, these
data indicate there was survival of USA300 in human blood after
120 min in culture (Fig. 1B).
S. aureus transcriptome dynamics in human blood and
serum
To obtain a comprehensive view of the molecules that promote S.
aureus survival in whole blood and thus facilitate bacteremia, we
measured global changes in USA300 gene expression during culture
in heparinized human blood and fresh serum using USA300-
specific oligonucleotide microarrays (Fig. 2 and Table S1). Principal
component analysis (PCA) indicated significant segregation of
bacterial transcripts depending on culture conditions, i.e., the
transcriptomes of USA300 cultured in TSB, serum, or blood were
clearly different (Fig. 2A). Genes were classified into functional
groups using clusters of orthologous groups of proteins (COGs)
(http://www.ncbi.nlm.nih.gov/COG/) and subjected to further
analyses (Fig. 2B). Compared with bacteria at the start of culture
(t = 0), genes involved in amino acid transport and metabolism,
defense mechanisms/virulence, and inorganic ion transport and
metabolism were the most numerous up- or down-regulated
molecules during culture in human blood and/or serum (Fig. 2B).
Within these groups, genes encoding proteins and enzymes that
facilitate biotin metabolism and valine, leucine and isoleucine
biosynthesis pathways were the most numerous differentially-
regulated molecules during culture in blood or serum.
Transcripts encoding proteins involved in iron or heme uptake
and/or binding, such as isdA, isdB, isdC, isdD, isdF, srtB, isdG isdI,
fhuA, fhuB, fhuG, sirA, sirB, and sirC, were highly up-regulated by
USA300 during culture in serum or blood compared with bacteria
at the start of culture (t = 0) (Fig. 3 and Table S1). Iron-regulated
surface determinants (Isd) of S. aureus are known to be critical for
binding, uptake and utilization of heme from host proteins [10,11].
The ferric hydroxamate uptake (Fhu) system [12–14] and
staphylococcal iron-regulated proteins (Sir) A, B, and C (SirABC)
[15,16] promote ferrisiderophore import in S. aureus (reviewed by
Beasley and Heinrichs [17]). Blood and serum contain low levels of
free iron, thereby explaining the increased levels of transcripts that
promote heme and iron uptake by USA300. We note that previous
transcriptome studies with Yersinia spp. cultured in human plasma
reported an increase in transcripts encoding proteins involved in
iron uptake [18,19].
Figure 1. Survival of USA300 in human blood. (A) Interaction of
USA300 with PMNs in blood. Blood smears from each time point were
prepared and cells were stained with a modified Wright-Giemsa. Black
arrows indicate selected S. aureus. (B) Growth/survival curves of USA300
cultured in human heparinized blood, human serum and TSB. Prior to
inoculation, bacteria were grown in TSB to mid-exponential phase of
growth. Cultures were incubated at 37uC with 5% CO2 for the indicated
time points and plated for determination of CFUs as described in
Methods.
doi:10.1371/journal.pone.0018617.g001
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A relatively limited number of genes encoding proven or
putative S. aureus virulence factors were up-regulated uniquely in
human blood or serum over the course of the 2-h culture period
(versus t = 0) (Fig. 4A). For example, transcripts encoding 12 super-
antigen like proteins, IgG-binding protein Sbi (sbi), Ear (ear),
intercellular adhesion protein B (icaB), extracellular fibrinogen-
binding protein (efb), chemotaxis-inhibiting protein (chp), murein
hydrolase regulator A and B (lrgA, lrgB), leukotoxin GH (lukG, lukH)
[20], alpha-hemolysin (hla), Panton-Valentine leukocidin (lukS-PV,
lukF-PV) and gamma hemolysin subunits A, B, and C (hlgA, hlgB,
hlgC) were up-regulated during culture in serum and/or human
blood compared with growth in TSB (Fig. 4A). Notably, hlgA, hlgB,
and hlgC were among the most highly up-regulated molecules in
blood (e.g., hlgA was up-regulated 145-fold at 90 min). The
increased levels of hlgA, hlgB, and hlgC were either specific to blood
or most pronounced in blood, and correspondingly, most of the
bacteria were rapidly ingested by PMNs. These findings are
consistent with our previous studies that reported up-regulation of
these molecules during PMN phagocytosis and in response to
neutrophil granule protein extracts [9,21].
To verify microarray results, five genes of interest were
subjected to TaqMan real-time quantitative reverse-transcriptase
PCR (Fig. 4B). For this purpose, we compared levels of hlgA, isdB,
spa, agrA, and clfB transcript by microarray and TaqMan analyses
after 90 min in culture with human blood (mRNA levels at 90 min
were compared to those at the start of the assay, t = 0). There was
Figure 2. Transcriptome dynamics of USA300 in human blood and serum. (A) Principal component analysis (PCA) of the S. aureus
transcriptome during culture in human blood, serum or TSB. Each shape represents an individual GeneChip (sample), with the plotted location based
upon the correlation of each sample relative to the others. The total amount of variation within the data set is 51.1% and each axis represents a
different principal component. (B) Numbers of differentially-regulated genes within each COG group.
doi:10.1371/journal.pone.0018617.g002
S. aureus Gene Expression in Human Blood
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Figure 3. USA300 transcripts encoding metal-associated proteins are differentially expressed following culture in serum or human
blood. Microarray results are presented as the mean fold-change of six separate experiments (blood and serum from six individuals) compared to
time point zero (t = 0). All transcripts met criteria for differentially-regulated genes as indicated in the Materials and Methods section. Common name
of the encoded protein is provided and gene names or ORF numbers are indicated in parentheses.
doi:10.1371/journal.pone.0018617.g003
S. aureus Gene Expression in Human Blood
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a strong positive correlation between TaqMan and microarray
data.
Gamma-hemolysin (HlgABC) contributes to
USA300-mediated lysis of human neutrophils
We next generated an isogenic hlgABC deletion strain of
USA300 (LACDhlgABC or DhlgABC) to investigate the potential
role of this toxin in USA300 virulence and immune evasion
(Fig. 5A and B). Growth of the wild-type and DhlgABC strains was
virtually identical in vitro (Fig. 5C). Because of the size of the
hlgABC operon, we were unable to generate a complemented
mutant strain for subsequent studies. However, direct comparison
of wild-type and DhlgABC strains by USA300-specific expression
microarrays indicated that the only difference between the two
strains was the absence of hlgABC transcript in the mutant strain
(these data are provided on the Gene Expression Omnibus at
http://www.ncbi.nlm.nih.gov/geo, GSE25454).
Compared with TSB or CCY culture media, brain-heart
infusion media (BHI) supported optimum expression of hlgA
transcript (Fig. 6A). Therefore, we compared BHI culture
supernatants from wild-type and DhlgABC strains for their ability
to induce formation of pores in the plasma membrane of human
PMNs (Fig. 6B). Although BHI culture supernatants from early
stationary phase of growth (7-h cultures) caused limited pore
formation (25.8615.2% at 30 min), those from wild-type strains
cultured to late stationary phase of growth (17-h cultures) caused
membrane pores in 69.2% of the PMNs (Fig. 6B). By comparison,
DhlgABC supernatants had significantly decreased capacity to
cause plasma membrane pores in human PMNs (5.362.7% for
the mutant strain at 30 min, P,0.001 vs. wild-type) (Fig. 6B).
Consistent with these findings, LACDhlgABC culture supernatants
had significantly reduced capacity to cause ultimate PMN lysis
(e.g., LDH release for a 1:50 dilution of wild-type supernatants at
6 h was 23.7610.6% versus 5.862.5% from that of the mutant
strain) (Fig. 6C). Taken together, these data indicate HlgABC can
contribute significantly to USA300-mediated lysis of human
PMNs under specific culture conditions.
Contribution of hlgABC to virulence in mouse infection
models
Based on the observation that hlgABC were highly up-regulated
during culture of USA300 in human blood, and since HlgABC
contributed to human PMN lysis in vitro, we compared virulence of
USA300 wild-type and DhlgABC strains in mouse models of skin
infection and bacteremia (Fig. 7A and B). Compared with the LAC
wild-type strain, LACDhlgABC caused abscesses that were of
comparable size, and the time required for resolution of abscesses
was similar between the strains (Fig. 7A). These observations are in
accordance with previous studies that evaluated the contribution
of Panton-Valentine leukocidin (PVL)—another two-component
leukotoxin—to virulence in the mouse skin infection model [22,23].
On the other hand, the DhlgABC strain caused moderately reduced
mortality compared with the wild-type strain in the mouse
bacteremia model at all times 36 h post-infection (for up to
192 h), albeit the difference was significant only at 72 h (Fig. 7B).
Consistent with data from the bacteremia model, survival of the
wild-type strain in human blood was greater than that of DhlgABC
through 90 min of culture (e.g., survival was 57.5613.1% for the
wild-type strain versus 33.065.2% for the DhlgABC strain at
60 min) (Fig. 7C). Collectively, these results suggest that if HlgABC
plays a role in USA300 virulence, the role is relatively minor and/
or the toxin is expressed only in specific host environments or
disease conditions. Alternatively, it is possible that function of
HlgABC is inhibited under certain conditions in vivo. Indeed, the
capacity of LAC culture supernatants to cause formation of pores in
the plasma membrane of human neutrophils was inhibited
significantly by the presence of 20–50% human serum or plasma
(Fig. 7D), a finding that merits further investigation.
It is also possible that functional redundancy with other two-
component leukotoxins (e.g., PVL and LukGH) masks in part any
potential contribution of HlgABC to disease in the mouse infection
models. In accordance with this notion, there was comparable
survival of the USA300 wild-type and DhlgABC strains after
phagocytic interaction with human neutrophils, and correspond-
ingly, lysis of PMNs after phagocytosis was essentially identical
(Fig. 7E and F). The idea that there is functional redundancy
among these molecules is tested in part below.
Figure 5. Construction and characterization of an isogenic
hlgABC deletion strain in USA300. (A) Schematic for deletion
hlgABC in strain LAC. (B) PCR confirmation of hlgABC deletion
mutagenesis. (C) Growth curves of the LAC wild-type and isogenic
hlgABC deletion strain (LACDhlgABC) cultured in TSB.
doi:10.1371/journal.pone.0018617.g005
Figure 4. Changes in the expression of USA300 transcripts encoding virulence/defense and gene regulation factors during culture
in blood. (A) Microarray data are presented as described in the legend of Fig. 3. (B) Verification of microarray data by TaqMan real-time reverse-
transcriptase PCR. Results are expressed as the average relative fold-change in transcripts from bacteria cultured in blood at 90 min compared to TSB
culture at t = 0. The relative quantification of S. aureus transcript was determined by the change in expression of target transcripts relative to gyrB as
described in Methods.
doi:10.1371/journal.pone.0018617.g004
S. aureus Gene Expression in Human Blood
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Relative contribution of USA300 leukotoxins to PMN
membrane pore formation in human PMNs
To better understand the level of functional redundancy among
USA300 two-component leukotoxins, we compared the ability of
USA300 wild-type and Dpvl, DhlgABC, DlukDE, DhlgABC/Dpvl,
Dpvl/DlukDE, or DhlgABC/DlukDE/Dpvl isogenic deletion strains
for their ability to cause plasma membrane pores in human PMNs
(Fig. 8). All USA300 strains were cultured in BHI media to late
stationary phase of growth, which promotes optimal expression of
hlgABC (Fig. 6A). Compared with culture supernatants from the
wild-type strain, those from DhlgABC, DhlgABC/Dpvl, or DhlgABC/
DlukDE/Dpvl strains had significantly reduced ability to cause pore
formation in human PMNs at all time points tested (Fig. 8B and
C). By comparison, BHI culture supernatants from the Dpvl strain
Figure 6. HlgABC causes PMN pore formation and cytolysis. (A) TaqMan real-time reverse transcriptase PCR analysis of hlgA and lukS-PV
expression in BHI, TSB and CCY media at mid-exponential (mid-log), early- and late stationary phases of growth. The relative quantification of S.
aureus genes was determined by the change in expression of target transcripts relative to that of gyrB. Membrane permeability (B) and lysis (C) of
human PMNs exposed to USA300 (LAC) BHI culture supernatants. PMNs were incubated with fresh BHI or BHI culture supernatants from wild-type
and DhlgABC strains as indicated. Early stationary or late stationary growth phase culture supernatants were diluted 1:500 and 1:2000 for pore
formation assays or 1:50, 1:250, and 1:500 for PMN lysis assays. *P#0.05 vs. DhlgABC.
doi:10.1371/journal.pone.0018617.g006
S. aureus Gene Expression in Human Blood
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had significantly reduced ability to cause PMN pore formation in
only 2 of the 6 conditions tested (Fig. 8B). Unexpectedly, culture
supernatants from neither the DlukDE nor Dpvl/DlukDE strains
caused PMN pore formation that was significantly decreased
compared to that from the wild-type strain (Fig. 8B). The finding
that PMN pore formation caused by culture supernatants from the
DlukDE and Dpvl/DlukDE strains (and in most assays the Dpvl
strain as well) were largely similar to that of the wild-type strain
indicates that pore formation in these assays was primarily caused
by HlgABC. It should be noted that in vitro assay conditions have a
significant impact on leukotoxin expression (e.g., see ref. [24]) and
similar assays performed with CCY culture media, in which PVL
is highly expressed, demonstrated PVL masks any potential role of
HlgABC (Fig. 8C). Conversely, longer incubation times using
CCY culture supernatants reveal that molecules other than PVL
cause PMN pore formation (e.g., see the limited pore formation
Figure 7. Contribution of hlgABC to USA300 virulence in mouse infection models and survival in human blood. (A) Abscess model.
Mice (15 per group) were infected with 16107 CFUs or wild-type or DhlgABC strains by subcutaneous injection into the right flank. Each symbol
represents average abscess area 6 SE on the indicated day. (B) Mouse survival. Mice (15 per group) were infected with 56107 CFUs of wild-type or
DhlgABC strains by tail vein injection and health was monitored for 14 d. *P,0.05 vs. DhlgABC. (C) Survival of wild-type and DhlgABC strains in
heparinized human blood. There were 1.56107 LAC wild-type CFUs at 0 min and this number decreased to 2.46106 CFUs by 120 min. *P,0.05 vs.
wild-type strain. Results are the mean 6 SE of 4 assays (4 blood donors). (D) Membrane permeability of human PMNs exposed to USA300 (LAC) BHI
culture supernatants in human serum or plasma. Supernatants from late stationary phase cultures of LAC were diluted 1:250 in RPMI (LAC BHI), serum
(serum + LAC BHI), or plasma (plasma + LAC BHI) as indicated and pore formation was measured as described in Methods. Control assays contained
PMNs in RPMI (RPMI), serum (20%), or plasma (20%) alone. Results are the mean6 SE of 3 experiments. *P#0.05 vs. LAC BHI. (E) Bacterial survival and
PMN lysis (F) after phagocytic interaction with wild-type or DhlgABC strains. Results for panels D and E are presented as the mean 6 SE for at least 6
independent experiments.
doi:10.1371/journal.pone.0018617.g007
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caused by Dpvl strains at 30 min in Fig. 8C). Taken together, these
results provide strong support to the idea that there is functional
redundancy among USA300 leukotoxins.
Discussion
Previous studies used expression microarray approaches to
investigate changes in the transcriptomes of group A Streptococcus
[25], Streptococcus agalactiae [26], and Enterococcus faecalis during
culture in human blood [27]. In addition to generating a
comprehensive view of the pathogen response to components of
human blood, these previous studies provide an important link
between animal models of infection and human disease.
In the present study, we used a similar microarray-based
approach to identify changes in the S. aureus transcriptome during
short-term (up to 2 h) culture in human blood and serum. Our in
Figure 8. Permeability of PMNs exposed to USA300 (SF8300) culture supernatants. (A) Confirmation of isogenic Dpvl, DhlgABC, DlukDE,
Dpvl/DlukDE, DhlgABC/lukDE/Dpvl and DhlgABC/Dpvl strains by PCR as described in Methods. For these experiments, we used a USA300 wild-type
strain known as SF8300 (which by molecular typing methods is essentially identical to LAC) to generate isogenic deletion mutants. (B) PMNs were
incubated with late stationary phase BHI culture supernatants at 1:500 and 1:250 dilutions. Results are the mean 6 SE of at least 5 PMN donors. (C)
PMNs were incubated with late stationary phase CCY culture supernatants at 1:500 and 1:250 dilutions. Results are the mean 6 SE of 2–5 PMN
donors. For panels B and C, *P,0.05 versus wild type or {P,0.05 as indicated using a repeated-measures ANOVA and Tukey’s posttest.
doi:10.1371/journal.pone.0018617.g008
S. aureus Gene Expression in Human Blood
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vitro model system is intended to simulate the effects of the host
environment imparted on S. aureus immediately after entering the
bloodstream. We compared S. aureus transcriptomes during culture
in whole blood or human serum separately as a means to
differentiate global responses to host cells present in whole blood
versus soluble factors present both in blood and serum. A
limitation of our comparison between serum and whole blood is
that serum lacks some of the soluble components present in plasma
and whole blood (fibrinogen and clotting factors), and S. aureus is
known to bind fibrinogen. Also, acute-phase proteins produced
during human infection will be absent in serum or plasma from
healthy individuals and these molecules could ultimately alter S.
aureus gene expression.
Although USA300 CFUs decreased at later time points (90–
120 min) during culture in blood, there was still significant survival
of the pathogen (,36106 CFUs or 32% after 120 min) (Fig. 1B).
There are two possible explanations for these observations. First,
these findings might be explained in part by the ability of PMNs to
kill some of the ingested USA300, since we demonstrated
previously that human PMNs kill about 50–70% of ingested
USA300 in vitro [8,9,23]. Alternatively, we observed that USA300
caused significant aggregation and clumping of host cells and
bacteria in blood at late time points (Fig. 1A) and this phenomenon
would decrease the number of recovered CFUs, since it was not
possible to completely disaggregate clumps of bacteria.
In addition to producing molecules directed to circumvent the
host immune system, S. aureus must adapt to the relatively limited
nutrient conditions in the bloodstream. A major growth limitation
in tissue fluids and blood is very low levels of free iron (10218 M),
and bacteria require iron at 0.4 mM to 4.0 mM [11,28]. Indeed,
our USA300 transcriptome analysis revealed that iron and iron
transport associated molecules are highly up-regulated during
incubation with human blood or serum, even at the earliest time
point measured (30 min) (Fig. 3 and Table S1). In addition to
adjusting to iron deficiency in blood or serum, S. aureus alters
expression of many genes encoding proteins involved in general
metabolism, findings consistent with transcriptome remodeling by
group A Streptococcus, Streptococcus agalactiae, and Enterococcus faecalis
during culture in human blood [25–27]. To support this
‘‘metabolic reset’’, up to 30% of all genes within a given COG
category, including secondary metabolites biosynthesis, nucleotide
transport and metabolism, amino acid transport and metabolism,
inorganic ion transport and metabolism, and coenzyme transport
and metabolism, were up-regulated by USA300 during culture in
blood or serum (Fig. 2B). Interestingly, genes encoding the global
regulators accessory gene regulator (Agr) and staphylococcal
accessory regulator (Sar) were down regulated during culture in
human blood or serum (but not in TSB cultures performed in
parallel), whereas saeR and saeS (saeRS) transcripts were up-
regulated (Fig. 4A and Table S1). The finding that genes encoding
SaeRS are up-regulated in blood only is consistent with previous
studies that indicate the genes are up-regulated during phagocy-
tosis by human PMNs.
Expression of staphylococcal virulence and defense factors is
largely controlled by two-component gene regulatory systems and
other global regulators, and gamma-hemolysin is no exception.
Yamazaki et al. [29] reported that expression of gamma-hemolysin
is regulated by Sae, observations compatible with our data
indicating that saeRS and hlgABC are up-regulated in blood.
Gamma-hemolysin is a unique two-component leukotoxin in the
sense that there are three genes encoded by the operon [30–32].
Two genes (hlgA and hlgC) encode LukS subunits and the other gene
(hlgB) encodes a LukF subunit [30–32]. These transcripts, especially
hlgA, are among the most up-regulated genes during culture of
USA300 in whole blood (hlgA was up-regulated 145-fold at 90 min,
hlgB and hlgC transcripts increased 34-fold compared to t = 0) (Table
S1). These data suggest that gamma-hemolysin contributes to
immune evasion and/or facilitates USA300 survival in blood.
Deletion of hlgABC did not affect survival of USA300 following
phagocytosis by human PMNs nor did it alter the ability of the
pathogen to cause PMNs lysis after phagocytosis (Fig. 7E and F).
Nonetheless, mice inoculated with LACDhlgABC had on average
20% increased survival in the bacteremia model compared with
mice infected with the LAC wild-type strain, and the mutant strain
had reduced survival in human blood (Fig. 7B and C). The modest
contribution of gamma-hemolysin to S. aureus virulence is
consistent with observations made in previous studies of the role
of gamma-hemolysin in animal infection models [33,34]. These
observations—i.e., lack of a role for hlgABC in USA300 survival
after phagocytosis and modest contribution to virulence in the
mouse—may seem at variance, but might be explained by
differences in toxin production and accumulation. Alternatively,
gamma-hemolysin could promote enhanced survival in blood by
causing erythrocyte lysis and thereby facilitate iron acquisition by
S. aureus. Gamma-hemolysin (HlgA + HlgB) was reported
previously as the most potent S. aureus hemolysin in vitro [35]
and iron acquisition is known to be a critical component of S.
aureus survival in the host [36,37]. The idea that hemolysins are
required for iron acquisition during infection is supported by
recent studies of Torres et al., who demonstrated that there is
coordinated expression of molecules involved in hemolysis/
cytolysis and iron uptake in S. aureus [38]. These findings are in
accordance with our microarray data (Fig. 3 and 4).
It is also possible that the role of individual USA300 leukotoxins
in animal infection models is largely masked by their redundancy
with the other two-component leukocidins or other cytolytic
molecules such as phenol-soluble modulins (PSMs) [39]. Leukotox-
in-specific phenotypes were revealed during culture of USA300 with
media and conditions that selectively favor high production of either
HlgABC or PVL (Fig. 8B and C). These data suggest that the
importance and/or level of expression of a particular leukotoxin
in vivo is influenced by the extracellular environment and/or
surrounding tissue. We recently reported that PMN pore formation
or lysis assays performed in vitro with S. aureus culture supernatants
have limited ability to inform about the relative contribution of PVL
to pathogenesis in vivo [24]. In accordance with this notion, BHI
culture supernatants from the DhlgABC strains had dramatically
reduced ability to cause PMN pore formation or lysis (Fig. 6 and
Fig. 8), but the contribution of hlgABC to virulence was limited by
comparison (Fig. 7A–C). Therefore, in vitro culture conditions for S.
aureus and those in vivo are likely much different, making
extrapolation of in vitro results with animal infections models less
predictable. In any case, more work will be required to determine
the specific role of this protein during S. aureus infection.
The global changes in USA300 gene expression reported here
provide a comprehensive view of the molecules that potentially
promote S. aureus immune evasion and survival in blood. We
focused our efforts on one finding from the microarray data
(changes in hlgABC expression), but investigation of the role of
other differentially-regulated molecules is likely to provide new
insights into the pathogenesis of S. aureus infection and may identify
new therapeutic targets.
Materials and Methods
Human subjects and ethics statement
Heparinized venous blood or venous blood without anticoag-
ulant was obtained from healthy human volunteers. The
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Institutional Review Board for Human Subjects, National Institute
of Allergy and Infectious Diseases, National Institutes of Health,
approved these studies (protocol 01-I-N055). Each person included
in the study provided written consent prior to enrollment.
Bacterial strains and culture
Culture conditions. Unless specified otherwise, bacteria
were grown in trypticase soy broth (TSB; Becton Dickinson) in a
flask-to-media volume ratio of 5:1 at 225 rpm at 37uC. Microarray
analyses were performed using a S. aureus USA300 strain known as
the Los Angeles County clone (LAC) [9]. To determine the
optimal culture conditions for hlgABC expression, LAC was
cultured in TSB, brain heart infusion media (BHI; Becton
Dickinson) and CCY media (3% yeast extract, 2% Bacto-
casamino acids, 0.21 M sodium pyruvate, 44 mM dibasic
sodium phosphate, 3 mM monobasic potassium phosphate,
pH 6.7) to the desired phase of growth. A USA300 DhlgABC
isogenic deletion strain was constructed as described below. For
PMN assays, bacteria were cultured in BHI media to early
stationary (7 h) or late stationary (17 h) phase of growth.
Construction of an isogenic hlgABC deletion strain
(DhlgABC). Isogenic hlgABC deletion in USA300 strain LAC
strain (LACDhlgABC or DhlgABC) was generated by a published
allelic replacement method [40]. Regions flanking the hlgABC
locus were amplified by PCR using the following primers:
Upstream fragment (1450 bp)
hlg_att1-F, 59-GGGGACAAGTTTGTACAAAAAAG-
CAGGCTGATAGAAGCCAACAAGTTTGGGTAG-39
hlg_att1-R, 59-CATAGAAATCACTTTCTTTC-
TATTTAATCTGCAGTTC-39
Downstream fragment (1650 bp)
hlg_att2-F, 59-GATACAAAAGAAACTGCAGACAA-
TAAATAGCTAG-39
hlg_att2-R, 59-GGGGACCACTTTGTACAAGAAA-
GCTGGGTGCATGTGGTGCATACGGGGGTGT-39
The att sequence is in bold-face type and restriction sites are
underlined. PCR products were digested with PstI and ligated
and cloned into pKOR1. The resulting plasmid, pKOR1Dhl-
gABC, was amplified in E. coli and electroporated into USA300
strain LAC and allelic replacement was performed as described
[40]. Isogenic deletion of hlgABC in LACDhlgABC strains was
verified by PCR. A USA300-specific Affymetrix oligonucleotide
microarray was used to compare LAC and LACDhlgABC strains
during growth in TSB (posted online at GSE25454). Using this
approach, hlgA, hlgB, and hlgC were the only USA300 transcripts
with a significant change in expression, thereby providing strong
evidence that no unintended mutations were generated in the
LACDhlgABC strain.
Construction of double- and triple mutant USA300
strains. A USA300 strain known as SF8300 [41], which is
essentially identical to strain LAC by molecular typing methods,
was used to construct single, double, and triple-deletion strains.
The isogenic lukS-PV and lukF-PV deletion strain (SF8300Dpvl or
Dpvl) was published previously [42] and was created as described
by Voyich et al. [23]. Isogenic deletion of hlgA, hlgB, and hlgC
(DhlgABC), lukD and lukE (DlukDE), DhlgABC/Dpvl, Dpvl/DlukDE,
or DhlgABC/DlukDE/Dpvl was performed in strain SF8300 or
SF8300Dpvl using a previously reported allelic replacement
method [40], essentially as described above for the LACDhlgABC
strain.
Microarray experiments
S. aureus strain LAC was cultured to mid-exponential phase of
growth (OD600,0.75), washed once with Dulbecco’s PBS (DPBS;
Sigma-Aldrich) and added to fresh TSB media, 100% normal
human serum, or human heparinized venous blood to a final
concentration 107 colony-forming units (CFU)/ml. Blood or
serum from 6 individuals was used for these experiments. Bacteria
were incubated with gentle rotation for up to 120 min at 37uC
with 5% CO2. At selected time points (0, 30, 60, 90 and 120 min)
10-ml samples were collected for subsequent analyses. A 1-ml
aliquot of each sample was centrifuged at 15006g (4000 rpm) for
5 min to pellet all bacteria, washed once with 1 ml of DPBS,
centrifuged again and resuspended in 1 ml of DPBS. 100 ml of the
sample was plated on trypticase soy agar (TSA) to enumerate
CFUs. A small fraction of the culture samples was used to prepare
a sample smear that was subsequently stained with Wright-Giemsa
and examined under a microscope (AxioSkop 2 Plus, Carl Zeiss).
The remaining sample was used for isolation of bacterial RNA.
S. aureus RNA was isolated from samples using an RNeasy Mini
Kit (Qiagen) combined with Bacterial-RNA Protect (Qiagen) as
described by the manufacturer. Contaminating chromosomal
DNA was removed by TurboDNase (Ambion/Applied Biosys-
tems) and samples were treated to MICROBEnrichTM (Ambion) to
remove eukaryotic RNA. Fragmented and biotin-dUTP-labeled
amplified mRNA was generated from purified staphylococcal
RNA using the MessageAmpTM II-Bacteria Kit (Ambion) accord-
ing to the manufacturer’s protocol. Samples were hybridized to a
custom Affymetrix GeneChip (RMLchip7, Gene Expression
Omnibus (GEO) platform GPL8069, http://www.ncbi.nlm.nih.
gov/projects/geo/) that contains all open reading frames of the
USA300 genome (100% coverage, 2560/2560 total ORFs).
Samples were scanned using the Affymetrix 7Gplus GeneChip
scanner according to standard GeneChip protocol with the image
files converted using GeneChip Operating Software (GCOS v1.4).
The TSB samples at time zero (t = 0)—i.e., bacteria cultured to
mid-exponential phase of growth as described above and washed
once but not incubated at 37uC—were used as controls for all
other samples and time points. Thus, all expression microarray
data are presented as the mean fold-change of 6 experiments
relative to that at t = 0. The data were quantile-normalized and a
3-way ANOVA with multiple test correction using the false
discovery rate (FDR, significance at 0.05) [43] was performed
using Partek Genomics Suite software (Partek, inc. St. Louis, Mo.,
v6.5 6091110). These data were combined with fold change
values, signal confidence (above background), and call consistency
(as a percent) as calculated using custom Excel templates to
generate final gene lists for each comparison (Table S1). A com-
plete set of microarray data has been posted online at http://www.
ncbi.nlm.nih.gov/projects/geo/ under series number GSE25454.
All microarray data are MIAME compliant.
TaqMan Real-Time Reverse Transcriptase PCR
RNA samples used in the microarray experiments were also
analyzed by TaqMan real-time RT-PCR. Purified S. aureus RNA
was subjected to One-Step TaqMan real-time PCR using an ABI
7500 thermocycler (Applied Biosystems). The relative quantifica-
tion of S. aureus mRNA was determined by change in the
expression level of the target transcripts relative to gyrB transcript
(housekeeping gene) [9], in accordance with the manufacturer’s
protocol (Applied Biosystems Relative Quantification Manual).
Data obtained are expressed as the mean fold-change in transcript
during culture in blood for 90 min relative to the t = 0 control
sample. Results are from three separate blood donors and samples
were analyzed in triplicate.
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Alternatively, RNA used for comparison of hlgA and lukS-PV
transcripts was isolated from LAC cultured to mid-exponential-,
early stationary-, or late stationary phase of growth in TSB, BHI,
or CCY media as described above. TaqMan analysis was
performed as described above.
Human neutrophil assays
PMNs were isolated by standard dextran sedimentation coupled
with Hypaque-Ficoll gradient centrifugation as described else-
where [44]. PMN bactericidal activity toward serum-opsonized S.
aureus and lysis of PMNs following phagocytosis of serum
opsonized bacteria were determined using published methods
[8,9,23]. Lysis of PMNs following exposure to filter-sterilized
BHI culture supernatants was determined by release of lactate
dehydrogenase (LDH) using a kit (Cytotoxicity Detection Kit,
Roche Applied Sciences) as recommended by the manufacturer
and as described [23,24]. PMN plasma membrane permeability
(pore formation) caused by USA300 culture supernatants was
assessed by uptake of ethidium bromide (EtBr) as described
[8,23,24].
Mouse infection models
Female CD1 Swiss and Crl:SKH1-E hairless mice (each 6–8
weeks old) were used for bacteremia and abscess models,
respectively. All studies conformed to guidelines set forth by the
National Institutes of Health and were reviewed and approved by
the Animal Use Committee at Rocky Mountain Laboratories,
National Institute of Allergy and Infectious Diseases (protocol
2010–24). Fifteen mice were used for each strain group and five
mice were used for the DPBS controls in each infection model. S.
aureus strains were cultured to mid-exponential phase of growth
(OD600,0.75) and washed twice with sterile DPBS. For the skin
abscess model, animals were inoculated subcutaneously with
0.05 ml of 16107 live S. aureus or sterile saline in the right flank
[22,23,45]. Mice were monitored and weighed daily over the
period of 14 days. Abscess area was calculated using formula
[A= p(L/2)6W/2], where (L) is length and (W) is width of an
abscess [46].
For the bacteremia model, animals received 56107 CFUs of
bacteria in 0.1 ml sterile saline by intravenous inoculation via tail-
vein injection [23]. Criteria for determining morbidity or sickness
in mice include hunched posture, decreased activity, ruffled fur,
and labored breathing. Following inoculation, animal health was
monitored every 3 h for the first 72 h and then every 8 h
thereafter for up to 194 h. Mice were euthanized if they were
unable to eat or drink or if they became immobile. In our
experience, mice do not recover from intravenous S. aureus
infection if they meet criteria for euthanasia. Therefore, mice
euthanized due to severe bacterial illness were scored as dead.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 5
(GraphPad Software, Inc., CA). Statistics for PMN pore formation
assays were determined using a one-way repeated-measures
analysis of variance (ANOVA) and Tukey’s posttest. PMN lysis
assays and assays for S. aureus survival in blood were analyzed using
a one-tailed paired t-test. Mouse survival statistics were evaluated
by two methods. First, survival curves were compared performed
using a standard log-rank test. In addition, differences in mouse
survival were assessed on each day using Fisher’s exact test.
Statistics for abscess area were performed using a one-way
ANOVA and Bonferroni’s posttest for multiple comparisons.
Supporting Information
Table S1 Changes in USA300 transcriptome, following
culturing in TSB, human serum or human heparinized
blood. Microarray results are presented as the mean fold-change
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fold-change (p value,0.05 and $2-fold change in transcriptome)
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control – TSB time point ‘‘0’’ or t = 0.
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